93 related articles for article (PubMed ID: 20649515)
1. Cardiac pre- and post-conditioning: implications in anesthesia?
Pesonen E
Acta Anaesthesiol Scand; 2010 Aug; 54(7):793-4. PubMed ID: 20649515
[No Abstract] [Full Text] [Related]
2. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury.
Kharbanda RK
Heart; 2010 Aug; 96(15):1179-86. PubMed ID: 20558460
[No Abstract] [Full Text] [Related]
3. Desflurane-induced cardioprotection against ischemia-reperfusion injury depends on timing.
Smul TM; Lange M; Redel A; Stumpner J; Lotz CA; Roewer N; Kehl F
J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):600-6. PubMed ID: 19167913
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic injection of PARP inhibitor INO-1001 preserves cardiac function in porcine myocardial ischemia and reperfusion without reducing infarct size.
Roesner JP; Mersmann J; Bergt S; Bohnenberg K; Barthuber C; Szabo C; Nöldge-Schomburg GE; Zacharowski K
Shock; 2010 May; 33(5):507-12. PubMed ID: 20395771
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
[TBL] [Abstract][Full Text] [Related]
6. The potential of pre and post conditioning to prevent cardiac ischemic sequelae.
Meijer RC; Kappetein AP; Serruys PW; Bogers JJ
Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):21-3. PubMed ID: 19618594
[No Abstract] [Full Text] [Related]
7. Post-conditioning with cyclosporine A fails to reduce the infarct size in an in vivo porcine model.
Lie RH; Stoettrup N; Sloth E; Hasenkam JM; Kroyer R; Nielsen TT
Acta Anaesthesiol Scand; 2010 Aug; 54(7):804-13. PubMed ID: 20455870
[TBL] [Abstract][Full Text] [Related]
8. Ischaemic conditioning for myocardial salvage after AMI.
Ibanez B; Fuster V
Lancet; 2010 May; 375(9727):1691; author reply 1692. PubMed ID: 20472164
[No Abstract] [Full Text] [Related]
9. [Ischemic postconditioning: an effective strategy of myocardial protection?].
Rastaldo R; Penna C; Cappello S; Mancardi D; Pagliaro P; Losano G
G Ital Cardiol (Rome); 2006 Jul; 7(7):464-73. PubMed ID: 16977786
[TBL] [Abstract][Full Text] [Related]
10. Anesthetic preconditioning: how important is it in today's cardiac anesthesia?
De Hert SG
J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):473-6. PubMed ID: 16884975
[No Abstract] [Full Text] [Related]
11. Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion.
Xie JR; Yu LN
Acta Anaesthesiol Scand; 2007 Aug; 51(7):909-13. PubMed ID: 17578461
[TBL] [Abstract][Full Text] [Related]
12. Realizing the clinical potential of ischemic preconditioning and postconditioning.
Yellon DM; Hausenloy DJ
Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of permeability transition and myocardic reperfusion damage by cyclosporine A].
Chávez E; García N; Pavón N
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-77-81. PubMed ID: 18938702
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of apoptosis in ischemic myocardium.
Scarabelli TM; Knight R; Stephanou A; Townsend P; Chen-Scarabelli C; Lawrence K; Gottlieb R; Latchman D; Narula J
Curr Probl Cardiol; 2006 Mar; 31(3):181-264. PubMed ID: 16503249
[TBL] [Abstract][Full Text] [Related]
15. Anaesthesia and myocardial ischaemia/reperfusion injury.
Frässdorf J; De Hert S; Schlack W
Br J Anaesth; 2009 Jul; 103(1):89-98. PubMed ID: 19502287
[TBL] [Abstract][Full Text] [Related]
16. 'Conditioning the heart' - lessons we have learned from the past and future perspectives for new and old conditioning 'drugs'.
Weber NC
Br J Pharmacol; 2015 Apr; 172(8):1909-12. PubMed ID: 25824658
[TBL] [Abstract][Full Text] [Related]
17. [Ischemic postconditioning and its application in organ transplantation].
Niu Y; Ye QF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):548-52. PubMed ID: 18600006
[TBL] [Abstract][Full Text] [Related]
18. ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!
Heusch G; Gersh BJ
Eur Heart J; 2016 Jan; 37(2):200-2. PubMed ID: 26508160
[No Abstract] [Full Text] [Related]
19. Rapamycin (sirolimus): a two-edged sword?
J Gross G
J Mol Cell Cardiol; 2006 Aug; 41(2):226-7. PubMed ID: 16781729
[No Abstract] [Full Text] [Related]
20. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
Skyschally A; Schulz R; Heusch G
Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
